WHITEHOUSE STATION, N.J. (AP) — Drugmaker Merck & Co. says the Food and Drug Administration is reviewing its second application to sell a new type of allergy treatment meant to gradually reduce allergic reactions over time, rather than just relieving sneezing, itching and other symptoms temporarily.
Merck's latest application is for an allergy immunotherapy tablet for ragweed allergies that dissolves under the tongue. Patients in studies of the tablet took it daily for a year.
It could become an alternative to months of uncomfortable allergy shots. Both methods gradually desensitize the immune system to the substance triggering the allergic reaction.
In March, the Whitehouse Station, N.J., company said the FDA was reviewing its application for an immunotherapy tablet for grass pollen allergies.
Merck expects FDA rulings on both still-unnamed treatments in 2014's first half.
Suspect in Custody After Shooting at Colorado Springs Planned Parenthood UPDATE: Three People Have Died, Shooter Identified | Christine Rousselle
Active Shooter Near Planned Parenthood Location in Colorado UPDATE: Suspect Has Surrendered to Police | Christine Rousselle
Reports: Active shooter barricaded in Colorado Springs Planned Parenthood, firing at cops; Update: Cops confronting shooter inside the building
Dr. Mark Skousen - When Will the Market Doomsayers and Permabears Be Right?
S.C. Woman Outdraws, Outshoots, And Kills CraigsList Robber - Bearing Arms - Guns Saving Lives, South Carolina
Planned Parenthood Shooter Finally Convinces Leftists that Beliefs Matter | RedState
Stumbling to War With Russia? | Human Events
'More white Christian terrorism?' Tweeters profile perp in reported Planned Parenthood shooting
John Hawkins - 15 Excerpts That Show How Radical, Weird And Out of Touch College Campuses Have Become